Live Breaking News & Updates on Sun Yat Sen University Cancer Center

Stay updated with breaking news from Sun yat sen university cancer center. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

HUTCHMED Highlights Presentations at the 2024 ASCO Annual Meeting

HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., May 23, 2024 HUTCHMED Limited today announces that new and updated data from several studies of compounds discovered by HUTCHMED will be. ....

Hangzhou , Zhejiang , China , Qing-zhai , Shanghai , Feng-wang , Hunan , United-states , Renji , Henan , Yang-wang , Shanxi

HUTCHMED Highlights Presentations at the 2024 ASCO Annual

HUTCHMED Highlights Presentations at the 2024 ASCO Annual
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

China , Guangzhou , Guangdong , Hangzhou , Zhejiang , Sheng-li , Anhui , Yang-wang , Shanxi , Chicago , Illinois , United-states

ASCO 2024 | Ascentage Pharma Releases Latest Results from Multiple Clinical Studies of Its Lead Drug Candidates

/PRNewswire/ Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and. ....

Zhejiang , China , Hong-kong , United-states , Hangzhou , Suzhou , Jiangsu , Chicago , Illinois , Guangzhou , Guangdong , Jilin

HUTCHMED Presentations at 2024 ASCO Annual Meeting | Company Announcement

Investegate announcements from HUTCHMED Presentations at 2024 ASCO Annual Meeting ....

Qing-zhai , Zhejiang , China , Zhengzhou , Henan , Yang-wang , Shanxi , Hong-kong , Tongji , Sichuan , Chicago , Illinois

Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial

Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial
plos.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from plos.org Daily Mail and Mail on Sunday newspapers.

Cairo , Al-qahirah , Egypt , South-korea , China , United-states , Cancer-institute , Guangdong , Jilin , Helsinki , Eteläuomen-läi , Finland